These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28134629)

  • 41. Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes.
    El-Armouche A; Bednorz A; Pamminger T; Ditz D; Didié M; Dobrev D; Eschenhagen T
    Biochem Biophys Res Commun; 2006 Aug; 346(3):700-6. PubMed ID: 16774736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein phosphatase 1 and an opposing protein kinase regulate steady-state L-type Ca2+ current in mouse cardiac myocytes.
    duBell WH; Rogers TB
    J Physiol; 2004 Apr; 556(Pt 1):79-93. PubMed ID: 14742732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
    Fan WJ; van Vuuren D; Genade S; Lochner A
    Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation.
    Valverde CA; Mundiña-Weilenmann C; Said M; Ferrero P; Vittone L; Salas M; Palomeque J; Petroff MV; Mattiazzi A
    J Physiol; 2005 Feb; 562(Pt 3):801-13. PubMed ID: 15528241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban.
    Sommerschild HT; Lunde PK; Deindl E; Jynge P; Ilebekk A; Kirkebøen KA
    J Mol Cell Cardiol; 1999 Oct; 31(10):1897-911. PubMed ID: 10525427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins.
    Müller-Ehmsen J; Nickel J; Zobel C; Hirsch I; Bölck B; Brixius K; Schwinger RH
    Basic Res Cardiol; 2003 Mar; 98(2):90-6. PubMed ID: 12607130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydrogen sulfide regulates cardiac sarcoplasmic reticulum Ca(2+) uptake via K(ATP) channel and PI3K/Akt pathway.
    Chen Y; Zhao J; Du J; Xu G; Tang C; Geng B
    Life Sci; 2012 Sep; 91(7-8):271-8. PubMed ID: 22884808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Astragalosides rescue both cardiac function and sarcoplasmic reticulum Ca²⁺ transport in rats with chronic heart failure.
    Wang Y; Ji Y; Xing Y; Li X; Gao X
    Phytother Res; 2012 Feb; 26(2):231-8. PubMed ID: 21656599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulated interaction of protein phosphatase 1 and protein phosphatase 2A with phospholipase C-related but catalytically inactive protein.
    Sugiyama G; Takeuchi H; Nagano K; Gao J; Ohyama Y; Mori Y; Hirata M
    Biochemistry; 2012 Apr; 51(16):3394-403. PubMed ID: 22458807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors.
    Fujiki H; Suganuma M
    Prog Mol Subcell Biol; 2009; 46():221-54. PubMed ID: 19184590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tautomycin's interactions with protein phosphatase 1.
    Sydnes MO; Isobe M
    Chem Asian J; 2010 Mar; 5(3):410-20. PubMed ID: 20013999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of cardiac function and expression and activity of myocardial calcium regulatory proteins in rabbit systolic and diastolic heart failure models.].
    Wang L; Zhang SJ; Wang HP; Zou C; Liu ZH
    Sheng Li Xue Bao; 2009 Dec; 61(6):551-8. PubMed ID: 20029689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphorylation status of matrix metalloproteinase 2 in myocardial ischaemia-reperfusion injury.
    Sariahmetoglu M; Skrzypiec-Spring M; Youssef N; Jacob-Ferreira AL; Sawicka J; Holmes C; Sawicki G; Schulz R
    Heart; 2012 Apr; 98(8):656-62. PubMed ID: 22397940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
    Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
    Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, biological evaluation, and pharmacokinetic study of novel liguzinediol prodrugs.
    Liu Z; Li W; Wen HM; Bian HM; Zhang J; Chen L; Chen L; Yang KD
    Molecules; 2013 Apr; 18(4):4561-72. PubMed ID: 23599014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PICOT increases cardiac contractility by inhibiting PKCζ activity.
    Oh JG; Jeong D; Cha H; Kim JM; Lifirsu E; Kim J; Yang DK; Park CS; Kho C; Park S; Yoo YJ; Kim DH; Kim J; Hajjar RJ; Park WJ
    J Mol Cell Cardiol; 2012 Jul; 53(1):53-63. PubMed ID: 22449794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.
    Gramolini AO; Trivieri MG; Oudit GY; Kislinger T; Li W; Patel MM; Emili A; Kranias EG; Backx PH; Maclennan DH
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2446-51. PubMed ID: 16461894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-18 gene deletion protects against sepsis-induced cardiac dysfunction by inhibiting PP2A activity.
    Okuhara Y; Yokoe S; Iwasaku T; Eguchi A; Nishimura K; Li W; Oboshi M; Naito Y; Mano T; Asahi M; Okamura H; Masuyama T; Hirotani S
    Int J Cardiol; 2017 Sep; 243():396-403. PubMed ID: 28526544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tautomycetin Synthetic Analogues: Selective Inhibitors of Protein Phosphatase I.
    Woydziak ZR; Yucel AJ; Chamberlin AR
    ChemMedChem; 2021 Mar; 16(5):839-850. PubMed ID: 33301228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2a.
    Huang H; Xie M; Gao L; Zhang W; Zhu X; Wang Y; Li W; Wang R; Chen K; Boutjdir M; Chen L
    Front Pharmacol; 2019; 10():221. PubMed ID: 30967774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.